HelpHelp About Us Contact Contact Us Help Help
Press Release Service
user name password
Client login:   
First time user sign up Forgot your login info?
Website Directory     Submit Website

Search
EmailWire News Links

Home > News By Company > Market Data Forecast.

Print e mail rss del Y! myWeb Tweet
 

Intravenous Ibuprofen Market Value Share, Supply Demand, share 2018 – 2023

Intravenous Ibuprofen Market - Global Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2018–2023)

 



(EMAILWIRE.COM, November 01, 2018 ) Global Intravenous Ibuprofen Market Overview:

Intravenous Ibuprofen IV is a non-steroidal anti-inflammatory drug (NSAID) used to reduce or treat pain, fever, and inflammation because of illness, surgery, or trauma, or acute illness. Ibuprofen IV is the preferred route of administration for the treatment of postoperative and acute pain. The demand for ibuprofen has increased due to the side effects of opioid analgesics, such as respiratory depression, allergic reactions, sedation and gastrointestinal events.

Global Intravenous Ibuprofen Market Size:

According to Market Data Forecast, The Global Intravenous Ibuprofen market was valued at USD 6.86 Billion, by the year 2023 it is expected to reach USD 17.07 Billion with 20.0% CAGR.

Request for Sample @ https://www.marketdataforecast.com/market-reports/intravenous-ibuprofen-market-6729/request-sample

Drivers and Restraints:

Increasing incidence of cancer, cardiovascular ailments, back pain, trauma and headache are the factors influencing the growth of the market. Increased demand for usage of non-opioids drugs. In 2015 FDA approved the use of Intravenous ibuprofen in pediatrics patients. Restraining factors of the market are side effects and the lengthy approval process.

Geographic Segmentation

Geographically, the Intravenous Ibuprofen market is segmented into North America, Europe, Asia-Pacific, Latin America and Middle East Asia. The Intravenous Ibuprofen market was dominated by North America. Asia Pacific is expected to grow at a high CAGR.

Major companies in the market are Cumberland Pharmaceuticals Inc., Alveda Pharmaceuticals, Inc., CSL Limited, Sandor Medicaids Pvt Ltd., Germin MED, Grifols S.A., Harbin Gloria Pharmaceuticals Co., Ltd., Al Nabeel International Ltd., PT. Soho Industry Pharmacy, and Laboratories Valmorca, C.A.

Browse Report Brief and TOC @ https://www.marketdataforecast.com/market-reports/intravenous-ibuprofen-market-6729/

Scope of the report:

The report offers a comprehensive analysis of the industry by providing the estimations of market potential and forecasts with utmost granularity. Along this, the factors influential in effecting the market dynamics and trends are discussed in detail at the product level. Further, the performance of the market at the regional and country-level is assessed and the prospects with high growth potential are identified and debated.

The key players in the industry are profiled providing insights on their financial performance, market position and growth strategies. Comparative analysis on prime strategically activities of the market players delineating the key developments like mergers & acquisitions, collaborations and an evaluation of the competitive environment within the industry are provided. The report also offers a broad outlook of the market along with recommendations from industry experts on the opportunities for investment activity.

What else? Apart from the syndicated report, our in-house team has an expertise and experience in designing custom reports to meet your specific research needs and assist you in making well-informed decisions.

Get your customized report: https://www.marketdataforecast.com/market-reports/intravenous-ibuprofen-market-6729/customize-report

About Us

Market Data Forecast is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients.

Contact Information:
Market Data Forecast.
Abhishek Shukla
Tel: +1-888-702-9626
Email us


----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results


 

Search


Advertising | How to contact us | Privacy Statement | EmailWire Press Releases | Partnership Opportunities

EmailWire is a press release distribution service of GroupWeb Media LLC.

© Copyright GroupWeb Media LLC 2023